Sign In
Buy AYTU
$2.09
-0.0100 (-0.476%)
At Close: Jun 03, 2026
Is Aytu BioScience, Inc. (AYTU) A Good Stock To Buy?
07:13pm, Friday, 05'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Aytu BioScience Announces Significant Improvement in Natesto(R) Patient Access in the United States
12:00pm, Wednesday, 03'rd Jun 2020
ENGLEWOOD, CO / ACCESSWIRE / June 3, 2020 / Aytu BioScience, Inc. (AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient
Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?
03:30pm, Tuesday, 02'nd Jun 2020
Is (AYTU) Outperforming Other Medical Stocks This Year?
Russia Says It's Developing UV Light Therapy to Treat Coronavirus
10:59am, Tuesday, 02'nd Jun 2020
Scientists warned about the dangers of UV radiation after U.S. President Trump suggested it as treatment.
Aytu BioScience Announces $15 Million Debt Retirement
08:01pm, Monday, 01'st Jun 2020
Company Retires $15M Obligation Assumed with Previously Announced Cerecor Commercial Portfolio Asset Purchase Company's Debt Reduced to Approximately $1 Million ENGLEWOOD, CO / ACCESSWIRE / June 1, 20
Aytu BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid Test
12:00pm, Monday, 01'st Jun 2020
Fourth FDA Emergency Use Authorization of a COVID-19 IgG/IgM Lateral Flow Rapid Test 1.4 Million Rapid Tests Available for Distribution at Company's Warehouse ENGLEWOOD, CO / ACCESSWIRE / June 1, 2020
Coronavirus Impact on Healthcare Acquired Infection Market
04:45pm, Tuesday, 26'th May 2020
May 26, 2020 (Heraldkeepers) --
New York, May 26, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
Aytu BioScience, Inc. (NASDAQ:AYTU): Is Breakeven Near?
12:40pm, Saturday, 16'th May 2020
Aytu BioScience, Inc.'s (NASDAQ:AYTU): Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing...
Aytu BioScience, Inc.'s (AYTU) CEO Joshua Disbrow on Q3 2020 Results - Earnings Call Transcript
12:34am, Friday, 15'th May 2020
Aytu BioScience, Inc. (NASDAQ:AYTU) Q3 2020 Results Earnings Conference Call May 14, 2020, 04:30 PM ET Company Participants Joshua Disbrow - Chairman & CEO
Aytu Bioscience, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates
11:15pm, Thursday, 14'th May 2020
Aytu Bioscience, Inc. (AYTU) delivered earnings and revenue surprises of 61.54% and 16.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Aytu BioScience Reports Third Quarter Fiscal 2020 Financial Results
08:01pm, Thursday, 14'th May 2020
Company Reports Revenue for the Three Months Ended March 31, 2020 of $8.2M, Up 243% Year-over-Year $62.5 Million in Cash and Cash Equivalents as of March 31, 2020 Management to Host Conference Call at
Acerus Pharmaceuticals' (ASPCF) CEO Ed Gudaitis on Q1 2020 Results - Earnings Call Transcript
08:01pm, Tuesday, 12'th May 2020
Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q1 2020 Earnings Conference Call May 12, 2020 8:30 AM ET Company Participants Bob Motz – Chief Financial Office
Acerus Reports First Quarter 2020 Financial Results
12:00am, Tuesday, 12'th May 2020
Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month perio
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Aytu Bioscience Inc (AYTU) Outpaces Stock Market Gains: What You Should Know
09:45pm, Thursday, 07'th May 2020
Aytu Bioscience Inc (AYTU) closed the most recent trading day at $1.47, moving +1.38% from the previous trading session.
